跳转至内容

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
所有图片(1)

主要文件

27487

Sigma-Aldrich

无水柠檬酸粉末

BioUltra, anhydrous, ≥99.5% (T)

登录查看公司和协议定价

选择尺寸

100 μG
CN¥5,397.94

CN¥5,397.94


预计发货时间May 19, 2025详情


获取大包装报价

选择尺寸

变更视图
100 μG
CN¥5,397.94

About This Item

线性分子式:
HOC(COOH)(CH2COOH)2
CAS号:
分子量:
192.12
Beilstein:
782061
EC 号:
MDL编号:
UNSPSC代码:
12161700
eCl@ss:
39021801
PubChem化学物质编号:
NACRES:
NA.25

CN¥5,397.94


预计发货时间May 19, 2025详情


获取大包装报价

等级

biotech. grade

质量水平

产品线

BioUltra

方案

≥99.5% (T)

表单

powder or crystals

expl. lim.

8 %, 65 °F

技术

cell culture | hybridoma: suitable

杂质

insoluble matter, passes filter test

灼烧残渣

≤0.05% (as SO4)

缺失

≤0.5% loss on drying, 110 °C

正在寻找类似产品? 访问 产品对比指南

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
791725251275C0759
Citric acid BioUltra, anhydrous, ≥99.5% (T)

27487

Citric acid

Citric acid anhydrous, free-flowing, Redi-Dri™, ACS reagent, ≥99.5%

791725

Citric acid

Citric acid ACS reagent, ≥99.5%

251275

Citric acid

Citric acid 99%

C0759

Citric acid

assay

≥99.5% (T)

assay

≥99.5%

assay

≥99.5%

assay

99%

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

powder or crystals

form

crystals

form

crystals

form

crystals

solubility

H2O: 1 M at 20 °C, clear, colorless

solubility

-

solubility

-

solubility

water: soluble 383 g/L at 25 °C

pH

1.0-2.0 (25 °C, 1 M in H2O)

pH

-

pH

-

pH

-

impurities

insoluble matter, passes filter test

impurities

Substances carbonizable by hot sulfuric acid, passes test

impurities

Substances carbonizable by hot sulfuric acid, passes test

impurities

-

一般描述

柠檬酸是三柱氨基酸分析的缓冲成分。[1]是放射性碘化抗体从活的鼠肿瘤细胞中解离的最佳缓冲液。[2]

应用


  • 改善土壤微生物组:柠檬酸已经被用于改变含盐泥滩的土壤细菌菌群,研究显示了其在可持续生态管理环境生物技术中的用途(Liu et al., 2024

  • 食品工业中的可生物降解包装:在食品化学领域,柠檬酸和聚乙烯醇被用于开发抗微生物包装,体现了其在食品安全和保藏中的潜力(Xu et al., 2024)。

  • 工程应用中的纳米材料合成:柠檬酸是用于超级电容器的杂化纳米材料绿色合成的关键成分,该研究强调了其在促进材料科学和工程的作用(Teixeira et al., 2024)。

  • 环境科学和污染物控制:该研究采用柠檬酸考察了环境系统中药物和纳米颗粒的共运输,有助于理解污染物动力学和迁移策略(Cui et al., 2024)。

  • 食品科学和技术:研究人员在素食软糖配方中使用了柠檬酸,该研究显示了其在食品开发中的多功能性及其对质构特性的影响(Rawat et al., 2024)。

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Eye Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    没有发现合适的版本?

    如果您需要特殊版本,可通过批号或批次号查找具体证书。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    R Ehrlich et al.
    Journal of immunological methods, 26(4), 345-353 (1979-01-01)
    Several low pH buffers were used in order to dissociate radioiodinated antibodies from sensitized living tumor cells. Three buffers were further tested for their dissociation abilities under different conditions of time and temperature, and for their influence on the eluted
    T N Ferraro et al.
    Analytical biochemistry, 143(1), 82-94 (1984-11-15)
    A highly resolving triple-column amino acid analyzer with fluorometric detection is described. The reliability of this technique was evaluated and it was used in a baseline investigation of amino acids and related compounds in human cerebrospinal fluid (CSF). The procedure
    Felix Schiele et al.
    mAbs, 7(5), 871-880 (2015-06-06)
    Novel oral anticoagulants are effective and safe alternatives to vitamin-K antagonists for anticoagulation therapy. However, anticoagulation therapy in general is associated with an elevated risk of bleeding. Idarucizumab is a reversal agent for the direct thrombin inhibitor, dabigatran etexilate (Pradaxa®)
    Maria José Garcia-Fernandez et al.
    Biofouling, 29(3), 261-271 (2013-02-27)
    Prevention and management of wound infections receive a lot of attention, since the presence of micro-organisms interferes with the wound-healing process. The aim of this work was to use cyclodextrins (CDs) to endow hydrogels and gauzes with the ability to
    Wayne B Batchelor et al.
    Circulation, 106(12), 1470-1476 (2002-09-18)
    The relative anti-aggregatory effects of currently prescribed platelet glycoprotein IIb/IIIa receptor antagonists during and after percutaneous coronary intervention for acute coronary syndromes have not been established. We randomized 70 acute coronary syndrome patients undergoing percutaneous coronary intervention to receive abciximab

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持